SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2019 St. Louis, MO
Activity/Course #:
: 05.11.19PC

Cost:
: Free
Release/Start Date:
: May 11 2019
Expiration Date:
: May 11 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 2.75 pharmacology hour(s)
Hardware/Software Requirements:

Saturday, May 11, 2019
Hyatt Regency St. Louis at the Arch
315 Chestnut Street
St. Louis, MO 63102
(314) 655-1234

Registration Fee
There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
Self-Parking is available at the hotel and at the Mansion House Garage, located directly behind the hotel at 330 N 4th St for $16.00 per day. This option is cash only.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:

  1. Recognize the risk for, and impact of, hypoglycemia in patients with diabetes; Integrate strategies to reduce the risk of glycemic variability into the care of patients with diabetes; Recognize how to use SMBG or newer CGM devices to reduce the risk of dysglycemia/hypoglycemia; Differentiate between available insulin preparations and their effects on glycemic variability and hypoglycemic risk.
  2. Describe nocturia’s impact on affected patients; Evaluate symptoms of Nocturia in affected patients in order to determine the source of symptoms; Assess current pharmacologic and non-pharmacologic nocturia management strategies; Differentiate the mechanisms of action, and safety and efficacy profiles of available and emerging therapies for nocturia.
  3. Utilize evidence-based strategies to diagnose patients presenting with headache; Identify associated conditions (e.g. depression), and red flags for potentially life-threatening causes of headache; Use evidence-based recommendations to prescribe treatment for patients presenting with acute or emergent headache pain; Develop collaborate management plans, emphasizing patient education on avoiding triggers that cause headache, and adherence to prescribed treatment strategies; Discuss newer pharmacologic targets for managing patients with Chronic Migraine.
  4. Review the epidemiology and impact of pseudobulbar affect (PBA); Discuss the importance of early recognition of PBA in the primary care, nursing home, and rehabilitation settings; Describe diagnostic tools and criteria for objective diagnosis of PBA; Utilize evidence-based therapies to effectively manage PBA.
  5. Discuss the latest 2018 ACC/AHA Multisociety Guideline on the Management of Blood Cholesterol to reduce the risk of cardiovascular disease; Incorporate current data surrounding non-statin therapy into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Overcome barriers to access for PCSK9 monoclonal antibody therapy.
  6. Recognize the pervasive nature and global impact of ADHD symptoms throughout the day; Describe the physical and psychologic morbidity and mortality associated with ADHD; Use ADHD assessment tools to aid in diagnosis, track, and measure changes in ADHD symptoms to optimize pharmacologic treatment, non-pharmacologic treatment, and symptom control throughout the day; Implement appropriate and individualized treatment regimens for patients with ADHD.

Agenda*

7:30-8:00 am
        
Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Marlene Wolf, MD, FAAFP
8:10-9:20   Insulin Therapy and Glycemic Variability: Strategies for Achieving Diabetes Goals While Minimizing Hypoglycemia
Jeff Unger, MD, FAAFP, FACE
9:20-10:30   Identification, Evaluation and Treatment of Nocturia in the Primary Care Setting in 2019
Matt T. Rosenberg, MD
10:30-10:50   Break
10:50-12:00 pm
  Managing Migraine: Primary Care for Primary Headaches
Jeff Unger, MD, FAAFP, FACE
12:00-1:10   Lunch
1:10-2:20   Crying and Laughing Inappropriately? Think Pseudobulbar Affect
James Wymer, MD, PHD, CPI, FAAN
2:20-3:30 A Case Based Approach to Lipids Management: Individualizing Targets and Reducing Risk
David Montgomery, MD, PhD, FACC
3:30-3:40 Break
3:40-4:50
  Bringing ADHD into Focus: Strategies for Individualizing Care
Greg Mattingly, MD
4:50   Summary of Key Points and Closing Remarks
Marlene Wolf, MD, FAAFP

*Agenda subject to change.

Faculty

Greg Mattingly, MD
Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
St. Louis, MO

David Montgomery, MD, PhD, FACC
Preventive Cardiologist & Managing Partner
PREventClinic, Inc
Atlanta, GA

Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI

Jeff Unger, MD, FAAFP, FACE
Assistant Clinical Professor of Family Medicine
UC Riverside School of Medicine
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, CA

James Wymer, MD, PHD, CPI, FAAN
University of Florida
Professor of Neurology, Director of Neuromuscular Division
Professor of Neurology
Gainesville, FL

Moderator

Marlene R. Wolf, MD, FAAFP
Clinical Assistant Professor of Family Medicine
Nova Southeastern University's College of Allopathic Medicine
Family Practice
Lifetime Medical Consulting, LLC
Coral Springs, FL

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
Senior Project Manager
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
Vice President of Operations
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA
Chief Executive Officer
Association of Black Cardiologists
New York, NY

Joshua F. Kilbridge
President and Creative Director
Kilbridge Associates
San Francisco, CA

Cedric Nazareth, MBBS
Medical Writer
Cedric Nazareth Medical Writing
Mississauga, ON

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7.0 contact hours of continuing education, which includes 2.75 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This educational activity is supported by an educational grant from Avanir Pharmaceuticals; an independent medical educational grant from Shire; educational funding provided by Amgen; in part by an educational grant from Ferring Pharmaceuticals, Inc.; and by an educational grant from Novo Nordisk, Inc.